Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the discussions demonstrate strong support and active engagement with the research, with users referencing specific data such as the Duke study and emphasizing the safety of HCQ in African Americans. The tone is analytical and sometimes assertive, reflecting a belief that the findings challenge previous assumptions, thereby suggesting the potential for meaningful shifts in medical practice.
Most discussions reflect support for the study’s conclusion that hydroxychloroquine is safe for G6PD-deficient individuals, especially in African American populations.
The majority of posts show high interest, referencing specific studies and mechanisms, indicating engagement with the research findings.
Many users cite the study directly, discuss related mechanisms like hemolysis risk, and advocate for consideration of treatment implications, demonstrating deep involvement.
Participants highlight the study’s significance in changing perceptions and treatment protocols, though some discussions remain more informational than decisively impactful.
See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWAC3 https://t.co/Iey8oGnsEB
@docdomeng That’s the conventional teaching, yes. But this research group at Duke challenged that notion and concluded otherwise. https://t.co/l8BS5zI7fm
No increased cases of hemolysis with G6PD and exposure to HCQ- no role for routine screening or withholding HCQ https://t.co/c9dKUWm10r
@NGoshay @NtmrInVttm @2RockRidge @NanHayworth @BayerUS Note that there is a published article demonstrating safety of hydroxychloroquine use in African American patients (https://t.co/pRdYRGT2pF)
@LUppsala @FZores @Damkyan_Omega Ça traîne depuis quelques années et c’est dans la notice du Vidal https://t.co/fvYSfTrCZN
@Banitoto This article investigates the caution of prescribing HCQ to patients with G6PDH deficiency, they concluded that there is no evidence to support this risk. Additionally, not all patients with G6PDH deficiency are at similar risk for hemolysis https://t.co/6u4neFcYVP
Professor Roger Seheult MD discusses recent data showing decreasing COVID-19 death rates and explores the potential role of N-acetylcysteine in reducing inflammation markers in hospitalized patients. Recorded on October…
This video reviews the safety of hydroxychloroquine in G6PD deficiency patients, showing minimal hemolysis risk and suggesting routine testing may not be necessary, especially for African American individuals.
RT @RogerSeheult: See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWA…
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
RT @YujiMarutani: Watch "Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data" on YouTube https://t.co/Htmxrj10tP
RT @RogerSeheult: See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWA…
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
RT @RogerSeheult: See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWA…
RT @RogerSeheult: See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWA…
See what we covered before: https://t.co/cdx4EYj8XR https://t.co/jiU8QenKj8 https://t.co/OE8K4z0kGA https://t.co/LzuNIFWAC3 https://t.co/Iey8oGnsEB
@marklunn123 @1foreverseeking @MerylFeral @SpartaJustice I don’t know about that. This was shown early to reduce deaths. https://t.co/VxgGSciU5F
@ColinWEvans @termined_d @CThor45 @AmitAryaMD https://t.co/xF955rhz5I
@_bonewizard @HeyNurseKat @ButHisEmails @6x10E23 @butterfly731d @DrAseemMalhotra @JInsulinResist https://t.co/VxgGScAvuf
https://t.co/mViZE1n0Qh
@CelineDucruet https://t.co/LwJwzu7uw2
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
RT @OneMinPsychic: Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/8iAZRgZ65N via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/8iAZRgZ65N via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/PUmztXTEjy via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/OEpYU5ly7l via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/PW8PtkE8CX via @YouTube
@WhyATater https://t.co/t2tEhcGTgy
@ItsDogeCoin I take NAC. It's good for you generally and helps with Covid as well. https://t.co/IxZzMVod0d
@b1joe Ok, keep it up
@mulkireena @EricTopol @PNASNews During the acute phase of infection N-acetyl cysteine (NAC) to treat oxidative stress https://t.co/bOYvzY0aTh
RT @MayKazem: No increased cases of hemolysis with G6PD and exposure to HCQ- no role for routine screening or withholding HCQ https://t.co/…
RT @MayKazem: No increased cases of hemolysis with G6PD and exposure to HCQ- no role for routine screening or withholding HCQ https://t.co/…
No increased cases of hemolysis with G6PD and exposure to HCQ- no role for routine screening or withholding HCQ https://t.co/c9dKUWm10r
2017 Duke study: no cases of hemolysis in G6PD def. Rx w/ HCQ found in >700 months exposure. Authors concluded, "These data do not support routine measurement of G6PDH levels or withholding HCQ therapy among African American patients w/G6PDH deficiency." https://t.co/l7NF4NBFWB
Watch "Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data" on YouTube https://t.co/Htmxrj10tP
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/wWLRejy9MP via @YouTube
Lorsqu'ils discutent d'une hémolyse oxydative potentielle avec l'hydroxychloroquine, les auteurs s'appuient sur le fait qu'ils n'ont pas été détectés sur une petite étude particulière https://t.co/20DzUz8uxA
@satrapo86 @Covid19Critical There’s no studies with the vac but we see it’s effect on Covid Here goes thru some of medical studies with it for Covid https://t.co/QOk9RfJTtG
@sonny8s @stkirsch 7/ Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data https://t.co/np8QU3Ndzd
@SarahSopran0 https://t.co/bxlV1RI9jL https://t.co/Q5d5FtwFyQ https://t.co/wDRjPfjapI I learned about it from medcram (links above) part of my prophylaxis protocol. I have bought from Amazon but now harder to get.
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data https://t.co/dvjRZhunYA
@MedCramVideos https://t.co/KYwtsdhGVz
@dmikeyanderson That's no good either - you taking your Vitamin D and NAC? https://t.co/aCrsk7kPvC https://t.co/bXRUCFyQyt
@FlaTesla @US_FDA If they did even the most basic research, they'd be supplementing heavily with vitamin D https://t.co/bXRUCFhfGV and taking NAC https://t.co/aCrsk73eE4
NAC is protective https://t.co/aCrsk73eE4
@juliefair Additionally - we use mouthwash with cetylpyridinium chloride (Colgate range + Supermarket own brand) + supplement called NAC (N-Acetylcysteine) Google it - here is a lecture from reputable Medcram with links to the research. https://t.co/NcsEIWlm3p
Decreasing mortality. https://t.co/ZmzUg76s40 Why? #COVID19
@Kristennetten N-acetl cysteine https://t.co/mDntIQAzeO
https://t.co/VjGTaKXB72
@DMCFFD Hey Dave, have a look at this video. https://t.co/06TuGaaW2p
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
RT @avivajazz: Coronavirus Update 114: COVID-19 Death Rate Among Hospitalized Patients Has Dropped Significantly Since March 2010; NAC (N-a…
@Cernovich NAC is also helpful for COVID-19. He starts talking about this around the 6 minute mark. He has other videos (~ 5 months ago) that go through the mechanism in more detail. I’m going to give it a go since it seems to have several benefits, thanks! https://t.co/yEFg6BVVvD
https://t.co/GvNcXOgIY9
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/YCye6ZoxDY via @YouTube
@TheRealPBarry alarmist metric! typical ABC...how about showing that the death rate is dropping...? https://t.co/fxCPK4OJID
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/s2436nTsHv via @YouTube
@DanielTuijnman @Nicole_Maes @MoniqueMeijde @Vrijheidsvogel Help me dan. Bekijk al die video's die jij EXPRES niet wil zien... Bedrieger die je bent. Vuilak. https://t.co/PKcuikQ8EQ https://t.co/xKTfa7usmN
https://t.co/xKTfa7usmN ''Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data'' DEATH RATES DROPS....
@MoniqueMeijde @Vrijheidsvogel @DanielTuijnman https://t.co/xKTfa7usmN Decrease in mortality. https://t.co/fCDvhLHcyK
https://t.co/Pc6xeS9PSH
Reduction in mortality percentage in USA and UK studies. #COVID19 https://t.co/2EY0WCssvE @MedCramVideos Significant to covid approach going forward. Treatments assisting Mask wearing? Vit D supplementation or more time outdoors in the sun? https://t.co/khVkUZK4lV
https://t.co/WG7HaVgkfA Positive cases up deaths rate down.This is the statistic that counts. Covid cases less serious over 99.97 survival rates and earlier and effective treatments now available.Democratics creating panic for political gain.
https://t.co/n3JWxjcBYt
I just love those MedCram videos. Great for reviewing my BioChem mechanisms. Nice to see deaths not going up with cases. https://t.co/xH8XUDpUkJ Wearing masks reduces virus doses saving lives. Also turns out NAC is effective for reducing inflammation in severe #COVID19 patients.
Watch "Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine) Data" on YouTube https://t.co/tf0MQ39zpJ
Really interesting data. Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/NprLWmB6XM via @YouTube
@__ice9 @joex92_ @Covid19Crusher @CovidAnalysis @gummibear737 Interesting talk on how HCQ could cause more deaths. Does anyone think this could explain why RECOVERY saw an increased death rate in the treatment group, in stark contrast to all other studies? https://t.co/L0z9oPPywV
Medcram https://t.co/WekhT3UEgN https://t.co/mocP3N0gma
Coronavirus Update 114: COVID 19 Death Rate Drops for hospital patients; NAC (N acetylcysteine... https://t.co/PsrgLhIlmU via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/CJz5DZEnee via @YouTube
RT @JSegor: 10-23-20: Big drop in COVID-19 death rates study says (US, UK), although current levels still too high, but flat. Here's why. (…
Coronavirus Update 114: COVID-19 Death Rate Among Hospitalized Patients Has Dropped Significantly Since March 2010; NAC (N-acetylcysteine and COVID-19; Face Masks — October 23, 2020 MedCram Update https://t.co/yFOmtanzKS via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/6PCEIwBYxH via @YouTube
@realDonaldTrump Here is the evidence we HAVE ‘turned the corner’ on Covid19 https://t.co/8GBS2MyycW https://t.co/jAR6x4YvXp
You can't necessary add the past data and apply the seasonal effect to find your result. Have to also consider we know how to medically manage this matter. Good info. Why the death rate dropped and NAC info for those who understands. https://t.co/t2VCRMubzn
MedCram Coronavirus Update 114: COVID 19 death rate drops; findings about NAC https://t.co/C9r4pR2nFF via @YouTube
RT @ckwadrat: Badania pokazują, że maseczki i dystans mogą obniżać śmiertelność po zachorowaniu na #COVID19. Z tej prostej przyczyny, że og…
I’ve positive experience with the use of NAC in #COVID19 pts. Today found more anecdotal evidence of benefits of NAC in #Covid19 pts. Original article https://t.co/6th4Zy4RxD https://t.co/6th4Zy4RxD related video https://t.co/4bfZh9Jima @aafp @AnnalsofIM @JAMA_current @WHO https://t.co/7Mqr2WHzDr
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
Worthwhile to look at and specially at use of NAC (N-acetyl cisteine) = Fluimukan in hospitalized pacients. Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/pqQquZPNyG via @YouTube
Coronavirus Update 114: COVID 19 Death Rate Drops; NAC (N acetylcysteine... https://t.co/idKLJHseAz via @YouTube
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
https://t.co/bjqZB3R89r
@chrisdbarnett @LFC_blano Thanks. I was just commenting on the risky behaviour People indigenous to warm climates clot more . With Covid this is a disadvantage, many small clots in the lungs is leading cause of death with most Covid patients. Medcram do a series of updates https://t.co/GMZ1wpso1m
RT @MedCramVideos: Professor Roger Seheult, MD on #COVID19 updates: - Death Rate Drops, but why? - NAC (N-acetylcysteine) data on hospita…
@axelmeyerko @brithume Well that is actually not accurate. You're talking about a G6PD deficiency, and out of ALL Of the literature of patients with this deletion, there were no cases of hemolysis. Nice they though. ;) https://t.co/KSu6H2oAW0
RT @elfaky_mahmoud: @Banitoto This article investigates the caution of prescribing HCQ to patients with G6PDH deficiency, they concluded th…
@Banitoto This article investigates the caution of prescribing HCQ to patients with G6PDH deficiency, they concluded that there is no evidence to support this risk. Additionally, not all patients with G6PDH deficiency are at similar risk for hemolysis https://t.co/6u4neFcYVP
https://t.co/gfp83nAE3J
RT @richardursomd: @NilooferN @niro60487270 Here it is https://t.co/x7NuiBUaqi
Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients. (notice that they examine effects on mainly white women, why when this effects mainly black men?) #watchthehands https://t.co/brprI7vUtf
@OffGuardian0 The trial 'proving' hydroxychloroquine is safe for G6PD-deficient patients was hopelessly skewed towards women. Only 2 G6PD-deficient men were part of the trial, and it's an x-linked disease that affects men far more than women! https://t.co/pNTJGy8emN
@NilooferN @niro60487270 Here it is https://t.co/x7NuiBUaqi
@MyGreenGypsy @Wewoka3 @zev_dr “These data do not support routine measurement of G6PDH levels or withholding HCQ therapy among African American patients with G6PDH deficiency.” https://t.co/uXvnlGfVgb
RT @richardursomd: @yota_berlin This ones better. https://t.co/igPcACKblm
@yota_berlin This ones better. https://t.co/igPcACKblm
@NilooferN @Ala_LK The study is called “Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH‐Deficient Patients”
@M_T_Franz jein, aber ich bin kein Mediziner https://t.co/G6qU4fw66g + Wodags Kausalitätsvermutung dank gut belegter Auffälligkeit bei der Sterblichkeit vs. https://t.co/4SDdVoFDwm
RT @ElieBalesh: @docdomeng That’s the conventional teaching, yes. But this research group at Duke challenged that notion and concluded othe…
RT @Le___Doc: @LUppsala @FZores @Damkyan_Omega Ça traîne depuis quelques années et c’est dans la notice du Vidal https://t.co/fvYSfTrCZN
@LUppsala @FZores @Damkyan_Omega Ça traîne depuis quelques années et c’est dans la notice du Vidal https://t.co/fvYSfTrCZN
RT @ElieBalesh: @docdomeng That’s the conventional teaching, yes. But this research group at Duke challenged that notion and concluded othe…
@Dr_Mike_Stevens This paper out of Duke informed my thinking not to check routinely. https://t.co/oGKDd4OYpc
@2Specialhalo @IraqimIL @moshebst https://t.co/ScBaUNZHVe
RT @ElieBalesh: @docdomeng That’s the conventional teaching, yes. But this research group at Duke challenged that notion and concluded othe…
@NoShoutStandOut @LernerHd @cameronks @EMNerd_ @ThinkingCC @emcrit @emupdates @srrezaie @EMSwami @PulmCrit @painfreeED @precordialthump @EvieMarcolini @4shikaJain @DFarcy @umanamd @gattinon @broomedocs @MRamzyDO @cnnbrk @drsanjaygupta @ChrisCuomo @NYGovCuomo They can’t take chloroquine but can take hydroxychloroquine. It has no adverse effects on g6pd https://t.co/sPGy7vivai
@docdomeng That’s the conventional teaching, yes. But this research group at Duke challenged that notion and concluded otherwise. https://t.co/l8BS5zI7fm
#SciencePrevails #TruthMatters #ClinicianNotes If good people do nothing, evil prevails. Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients. - PubMed - NCBI @NAACP @NationalBaptist https://t.co/PQKao8m3t7
RT @davidNbreslauer: @NGoshay @NtmrInVttm @2RockRidge @NanHayworth @BayerUS Note that there is a published article demonstrating safety of…
RT @davidNbreslauer: @NGoshay @NtmrInVttm @2RockRidge @NanHayworth @BayerUS Note that there is a published article demonstrating safety of…
RT @davidNbreslauer: @NGoshay @NtmrInVttm @2RockRidge @NanHayworth @BayerUS Note that there is a published article demonstrating safety of…
@NGoshay @NtmrInVttm @2RockRidge @NanHayworth @BayerUS Note that there is a published article demonstrating safety of hydroxychloroquine use in African American patients (https://t.co/pRdYRGT2pF)
doi:10.1002/acr.23296 . PMID 28556555 . 28. Schrezenmeier E, Dörner T (March 2020). "Mechanisms of action of hydroxychloroquine and chloroquine ...
Received: 4 November 2019 | Revised: 20 January 2020 | Accepted: 18 February 2020. DOI: 10.1002/jcla.23296 ... ACR Recommendations For The Use of ...
doi:10.1002/acr.23296. ISSN 2151-4658. PMID 28556555. ^ Kalia, S; Dutz, JP (2007). “New Concepts in Antimalarial Use and Mode of Action in Dermatology ...
“Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients”. Arthritis Care & Research. 70 (3): 481–485. doi:10.1002/acr.23296.
10.1002/adbi.201900312. PMID: 32519463; PMCID: PMC7718424. 19 ... ACR Appropriateness Criteria® Malignant or Aggressive. Primary ...
doi:10.1002/acr.23296. Acknowledgment 9. Browning DJ. Pharmacology of chloroquine and hydroxy- The authors have no acknowledgements to make ...
doi:10.1002/acr.23296. ISSN 2151-4658. PMID 28556555. ^ Kalia, S; Dutz, JP (2007). “New Concepts in Antimalarial Use and Mode of Action in ...
doi: 10.1002 / acr.23296. Epub 2018 Feb 9. 4. Glucose-6-phosphate dehydrogenase deficiency: Clinical presentation and eliciting factors ...
doi:10.1002/acr.23296. ISSN 2151-4658. PMID 28556555. ^ Kalia, S; Dutz, JP (2007). “New Concepts in Antimalarial Use and Mode of Action in ...
doi: 10.1002/acr.23296. ISSN 2151-4658. PMID 28556555. ^ Kalia, S; Dutz, JP (2007). "New Concepts in Antimalarial Use and Mode of Action in ...
doi:10.1002/acr.23296. ISSN 2151-4658. PMID 28556555. ^ Kalia, S; Dutz, JP (2007). “New Concepts in Antimalarial Use and Mode of Action in ...
2017;doi:10.1002/acr.23296. Healio AI. Ask a clinical question and tap into Healio AI's knowledge base. PubMed, enrolling/recruiting trials ...
EM
MH
DB
LD
ME
DL
AM
U
FF
L
AH
PV
DK
BB
TF
DU
MB
TL
BM
ES
BY
DM
ML
AK
L
R
AC
DW
P
CC
ND